Back
Neonode, Inc. 10K Form
Sell
37
NEON
Neonode, Inc.
Last Price:
$2.47
Seasonality Move:
4.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | NEON/Neonode, Inc. Quarterly |
| 2024-02-28 | 10K | NEON/Neonode, Inc. Annual |
| 2023-11-09 | 10Q | NEON/Neonode, Inc. Quarterly |
| 2023-08-10 | 10Q | NEON/Neonode, Inc. Quarterly |
| 2023-05-11 | 10Q | NEON/Neonode, Inc. Quarterly |
| 2023-03-09 | 10K | NEON/Neonode, Inc. Annual |
Receive NEON News And Ratings
See the #1 stock for the next 7 days that we like better than NEON
NEON Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1M |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.60 |
| Price / Book: | 1.46 |
Profitability
| EPS (TTM): | 0.53520 |
|---|---|
| Net Income (TTM): | $8.7M |
| Gross Margin: | $2.9M |
| Return on Equity: | 49.02% |
| Return on Assets: | 42.16% |
Neonode, Inc. Earnings Forecast
Key Neonode, Inc. Financial Ratios
-
The Gross Profit Margin over the past 41 years for NEON is 94.14%.
-
The Selling, General & Administrative Expenses for NEON have been equal to 196.11% of Gross Profit Margin.
-
The Research & Development expenses have been 110.81% of Revenue.
-
The Net Earning history of NEON is -189.03% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 22 years.
Neonode, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | NEON |
| CUSIP: | 64051M |
| Website: | neonode.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 5.43 |
| Quick Ratio: | 2.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NEON Technical Analysis vs Fundamental Analysis
Sell
37
Neonode, Inc. (NEON)
is a Sell
Is Neonode, Inc. a Buy or a Sell?
-
Neonode, Inc. stock is rated a SellThe current Neonode, Inc. [NEON] share price is $2.33. The Score for NEON is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.